โ† All deals

Stereotaxis, Inc.

Other Health CareB2BMedical EquipmentRobotics
๐Ÿ“ St Louis, Missouri, United Statesโ€ข Founded 1990
StreetZero Signal 67
Be the first to signal interest

About Stereotaxis, Inc.

Stereotaxis, Inc. is a public company headquartered in St. Louis, Missouri, that develops robotic systems for minimally invasive endovascular interventions, primarily in cardiac procedures. The company manufactures medical equipment and has treated over 150,000 patients globally across the US, Europe, Asia, and other regions. It operates a B2B business model and is listed on NYSE under STXS. Founded in 1990, it maintains a website at www.stereotaxis.com and LinkedIn presence with over 13,000 followers.

LATEST FUNDINGPrivate Placement
$12.0M
Announced 2026-11-19
TOTAL RAISED$166.5M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Stereotaxis, Inc..

Free plan includes 3 full deal profiles every month.

EMPLOYEESโ€”
FOUNDED1990
HQSt Louis, Missouri, United States
Industry
Other Health Care
Tags
B2BMedical EquipmentRoboticsPublic Company

Key highlights

  • Stereotaxis has raised $12 million via private placement with investors not disclosed.
  • The company has completed 11 funding rounds totaling $166.5 million including multiple post-IPO equity rounds.
  • Its robotic systems have been used in over 150,000 patient procedures worldwide.
  • Recent financing includes a $12.5 million registered direct offering to support commercialization and R&D.
  • Headquartered in St. Louis, the public company focuses on minimally invasive endovascular surgical robotics.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account